Calcium (Ca(2+)) dysregulation is a hallmark feature of cardiovascular disease. Intracellular Ca(2+) regulation is essential for proper heart function and is controlled by the sarco/endoplasmic reticulum Ca(2+) ATPase (SERCA2a). Another-regulin (ALN) is a newly discovered cardiomyocyte-expressed SERCA2a inhibitor, suggesting cardiomyocyte Ca(2+)-handling is more complex than previously appreciated. To study the role of ALN in cardiomyocytes, we generated ALN null mice (knockout, KO) and found that cardiomyocytes from these animals displayed enhanced Ca(2+) cycling and contractility compared to wildtype (WT) mice, indicating enhanced SERCA2a activity. In vitro and in vivo studies show that ALN is post-translationally modified via phosphorylation on Serine 19 (S19), suggesting this contributes to its ability to regulate SERCA2a. Immunoprecipitation and FRET analysis of ALN-WT, phospho-deficient ALN (S19A), or phosphomimetic ALN (S19D) revealed that S19 phosphorylation alters the SERCA2a-ALN interaction, leading to relief of its inhibitory effects. Adeno-associated virus mediated delivery of ALN-WT or phospho-mutant ALN-S19A/D in ALN KO mice showed that cardiomyocyte-specific expression of phospho-deficient ALN-S19A resulted in increased SERCA2a inhibition characterized by reduced rates of cytoplasmic Ca(2+) clearance compared to ALN-WT and ALN-S19D expressing cells, further supporting a role for this phosphorylation event in controlling SERCA2a-regulation by ALN. Levels of ALN phosphorylation were markedly increased in cardiomyocytes in response to Gα(q) agonists (angiotensin II, endothelin-1, phenylephrine) and Gα(q)-mediated phosphorylation of ALN translated to increased Ca(2+) cycling in cardiomyocytes from WT but not ALN KO mice. Collectively, these results indicate that ALN uniquely regulates Ca(2+) handling in cardiomyocytes via integration of neuroendocrine signaling with SERCA2a activity.
Another-regulin regulates cardiomyocyte calcium handling via integration of neuroendocrine signaling with SERCA2a activity.
另一种调节蛋白通过整合神经内分泌信号与 SERCA2a 活性来调节心肌细胞钙处理
阅读:5
作者:Hassel Keira R, Gibson Aaron M, Å eflová Jaroslava, Cho Ellen E, Blair N Scott, Van Raamsdonk Catherine D, Anderson Douglas M, Robia Seth L, Makarewich Catherine A
| 期刊: | Journal of Molecular and Cellular Cardiology | 影响因子: | 4.700 |
| 时间: | 2024 | 起止号: | 2024 Dec;197:45-58 |
| doi: | 10.1016/j.yjmcc.2024.10.008 | 研究方向: | 信号转导、免疫/内分泌、神经科学、细胞生物学 |
| 疾病类型: | 心肌炎 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
